Cargando…

Stigma of dementia during the COVID-19 pandemic: a scoping review protocol

INTRODUCTION: Dementia-related stigma reduces the quality of life of people living with dementia and their care partners. However, there is a dearth of literature synthesising knowledge on stigma of dementia during the COVID-19 pandemic. This scoping review protocol outlines a methodology that will...

Descripción completa

Detalles Bibliográficos
Autores principales: Bacsu, Juanita-Dawne R, Rahemi, Zahra, Nanson, Kate, Webster, Claire, Norman, Myrna, Spiteri, Raymond J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465918/
https://www.ncbi.nlm.nih.gov/pubmed/37643852
http://dx.doi.org/10.1136/bmjopen-2023-076300
_version_ 1785098770832162816
author Bacsu, Juanita-Dawne R
Rahemi, Zahra
Nanson, Kate
Webster, Claire
Norman, Myrna
Spiteri, Raymond J
author_facet Bacsu, Juanita-Dawne R
Rahemi, Zahra
Nanson, Kate
Webster, Claire
Norman, Myrna
Spiteri, Raymond J
author_sort Bacsu, Juanita-Dawne R
collection PubMed
description INTRODUCTION: Dementia-related stigma reduces the quality of life of people living with dementia and their care partners. However, there is a dearth of literature synthesising knowledge on stigma of dementia during the COVID-19 pandemic. This scoping review protocol outlines a methodology that will be used to understand the impact of stigma on people living with dementia during the pandemic. Addressing dementia-related stigma is critical to promoting timely dementia diagnoses and enhancing the quality of life for people living with dementia and their care partners. METHODS AND ANALYSIS: This review will follow the Arksey and O’Malley methodological framework and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews checklist. The review will focus on English-language, peer-reviewed literature published between 13 January 2020 and 30 June 2023. Stigma will be broadly defined according to pre-established components (stereotypes, prejudice and discrimination). We will search six databases including CINAHL, EMBASE, Google Scholar, Medline, PsycINFO and Web of Science. We will also hand-search the reference lists of relevant articles to identify additional manuscripts. Two reviewers will develop the data extraction table, as well as independently conduct the data screening. Any disagreements will be resolved through open discussion between the two researchers, and if necessary, by consulting the full team to achieve consensus. Data synthesis will be conducted using an inductive thematic analysis approach. ETHICS AND DISSEMINATION: This review will be the first to explore the impact of dementia-related stigma during the COVID-19 pandemic. An advisory panel including a person living with dementia and a care partner will be consulted to inform our review’s findings and support the data dissemination process. The results of this scoping review will be shared and disseminated through publication in a peer-reviewed journal, presentations at academic conferences, a community workshop and webinars with various stakeholders.
format Online
Article
Text
id pubmed-10465918
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-104659182023-08-31 Stigma of dementia during the COVID-19 pandemic: a scoping review protocol Bacsu, Juanita-Dawne R Rahemi, Zahra Nanson, Kate Webster, Claire Norman, Myrna Spiteri, Raymond J BMJ Open Geriatric Medicine INTRODUCTION: Dementia-related stigma reduces the quality of life of people living with dementia and their care partners. However, there is a dearth of literature synthesising knowledge on stigma of dementia during the COVID-19 pandemic. This scoping review protocol outlines a methodology that will be used to understand the impact of stigma on people living with dementia during the pandemic. Addressing dementia-related stigma is critical to promoting timely dementia diagnoses and enhancing the quality of life for people living with dementia and their care partners. METHODS AND ANALYSIS: This review will follow the Arksey and O’Malley methodological framework and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews checklist. The review will focus on English-language, peer-reviewed literature published between 13 January 2020 and 30 June 2023. Stigma will be broadly defined according to pre-established components (stereotypes, prejudice and discrimination). We will search six databases including CINAHL, EMBASE, Google Scholar, Medline, PsycINFO and Web of Science. We will also hand-search the reference lists of relevant articles to identify additional manuscripts. Two reviewers will develop the data extraction table, as well as independently conduct the data screening. Any disagreements will be resolved through open discussion between the two researchers, and if necessary, by consulting the full team to achieve consensus. Data synthesis will be conducted using an inductive thematic analysis approach. ETHICS AND DISSEMINATION: This review will be the first to explore the impact of dementia-related stigma during the COVID-19 pandemic. An advisory panel including a person living with dementia and a care partner will be consulted to inform our review’s findings and support the data dissemination process. The results of this scoping review will be shared and disseminated through publication in a peer-reviewed journal, presentations at academic conferences, a community workshop and webinars with various stakeholders. BMJ Publishing Group 2023-08-29 /pmc/articles/PMC10465918/ /pubmed/37643852 http://dx.doi.org/10.1136/bmjopen-2023-076300 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Geriatric Medicine
Bacsu, Juanita-Dawne R
Rahemi, Zahra
Nanson, Kate
Webster, Claire
Norman, Myrna
Spiteri, Raymond J
Stigma of dementia during the COVID-19 pandemic: a scoping review protocol
title Stigma of dementia during the COVID-19 pandemic: a scoping review protocol
title_full Stigma of dementia during the COVID-19 pandemic: a scoping review protocol
title_fullStr Stigma of dementia during the COVID-19 pandemic: a scoping review protocol
title_full_unstemmed Stigma of dementia during the COVID-19 pandemic: a scoping review protocol
title_short Stigma of dementia during the COVID-19 pandemic: a scoping review protocol
title_sort stigma of dementia during the covid-19 pandemic: a scoping review protocol
topic Geriatric Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465918/
https://www.ncbi.nlm.nih.gov/pubmed/37643852
http://dx.doi.org/10.1136/bmjopen-2023-076300
work_keys_str_mv AT bacsujuanitadawner stigmaofdementiaduringthecovid19pandemicascopingreviewprotocol
AT rahemizahra stigmaofdementiaduringthecovid19pandemicascopingreviewprotocol
AT nansonkate stigmaofdementiaduringthecovid19pandemicascopingreviewprotocol
AT websterclaire stigmaofdementiaduringthecovid19pandemicascopingreviewprotocol
AT normanmyrna stigmaofdementiaduringthecovid19pandemicascopingreviewprotocol
AT spiteriraymondj stigmaofdementiaduringthecovid19pandemicascopingreviewprotocol